Advertisement

The Scientist

» drug development and microbiology

Most Recent

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

image: Underground Immunity

Underground Immunity

By | July 16, 2015

Arabidopsis thaliana defense hormones shape the plant’s root microbiome. 

0 Comments

image: Microbiome Teams Up Against <em>C. diff</em>

Microbiome Teams Up Against C. diff

By | July 14, 2015

Researchers build a mathematical model that can predict whether a mouse will be infected by Clostridium difficile based on the microbes found in its GI tract.

1 Comment

image: Evolution of Kin Discrimination

Evolution of Kin Discrimination

By | July 6, 2015

A bacterium’s ability to distinguish self from non-self can arise spontaneously, a study shows, reigniting questions of whether the trait can be considered an adaptation.

3 Comments

image: MERS Help on the Horizon?

MERS Help on the Horizon?

By | July 1, 2015

New research finds that a treatment for Middle East respiratory syndrome can prevent and treat the disease in mice, while an experimental vaccine moves into human testing.

0 Comments

image: Gutless Worm

Gutless Worm

By | July 1, 2015

Meet the digestive tract–lacking oligochaete that has fueled Max Planck researcher Nicole Dubilier’s interest in symbiosis and marine science.

0 Comments

image: Sold on Symbiosis

Sold on Symbiosis

By | July 1, 2015

A love of the ocean lured Nicole Dubilier into science; gutless sea worms and their nurturing bacterial symbionts keep her at the leading edge of marine microbiology.

0 Comments

image: Sponging Up Phosphorus

Sponging Up Phosphorus

By | July 1, 2015

Symbiotic bacteria in Caribbean reef sponges store polyphosphate granules, possibly explaining why phosphorous is so scarce in coral reef ecosystems.

1 Comment

image: The Sum of Our Parts

The Sum of Our Parts

By and | July 1, 2015

Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

14 Comments

image: Organ-on-a-Chip Gets Big Pharma Boost

Organ-on-a-Chip Gets Big Pharma Boost

By | June 18, 2015

Johnson & Johnson agrees to use Emulate’s blood-clot device in three of its preclinical drug programs.

0 Comments

Advertisement

Popular Now

  1. How Fats Influence the Microbiome
  2. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  3. Opinion: Engineering the Epigenome
  4. Psychology’s Failure to Replicate
Advertisement
Advertisement